Table 1.
Data Set | Leukemia | CNS | DLBCL | Colon | Prostate1 | Prostate2 | Prostate3 | Lung | GCM | BRCA1 |
TST | 98% | 82% | 95% | 92% | 93% | 67% | 95% | 98% | 82% | 77% |
TSP | 91% | 73% | 98% | 93% | 89% | 69% | 91% | 94% | 79% | 66% |
The classification rates are estimated by leave-one-out cross validation. In both cases, the genes are restricted to a subset of differentially expressed genes based on a Wilcoxon rank test; the details appear in §2.3 and §3.1. The subsets are selected to ensure that the number of possible two-gene and three-gene classifiers are the same.